Celonib 400 mg Tablet
22,59$
7,37$
Celonib 400 mg Tablet is a targeted anticancer therapy designed to combat specific forms of leukemia and various blood cell disorders, providing hope for patients facing these challenging conditions. This medication is particularly effective against gastrointestinal stromal tumors (GIST), which are tumors that can form within the digestive tract walls and have the potential to metastasize. Additionally, Celonib is utilized for treating protuberant tumors that cannot be surgically excised, have metastasized, or have recurred post-surgery. By inhibiting certain proteins involved in tumor growth, Celonib helps to slow down or stop the progression of these cancers, making it a crucial option in oncological treatment plans. It's important to use this medication under the guidance of a healthcare professional, as it may come with potential side effects and interactions that need monitoring. Patients should be aware of possible warnings related to heart function and liver health while undergoing treatment with Celonib. Overall, Celonib 400 mg Tablet represents a vital component in the fight against various cancers, offering patients a pathway towards better health outcomes.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Celonib 400 mg tablet is primarily utilized in the treatment of Chronic Myelogenous Leukemia (CML). This condition involves the uncontrolled growth of blood-forming cells in the bone marrow. By targeting the underlying mechanisms of this cancer, Celonib 400 mg tablet helps to manage the disease effectively. Patients using this medication often experience improved blood cell counts and overall health.
• In individuals diagnosed with CML, Celonib 400 mg tablet plays a crucial role in inhibiting the progression of the disease. It works by interfering with specific proteins that promote cancer cell growth. This targeted approach allows for better management of symptoms and can lead to a reduction in the risk of complications associated with CML. Regular use of Celonib 400 mg tablet is essential for maintaining treatment efficacy.
• Celonib 400 mg tablet is often prescribed as part of a comprehensive treatment plan for patients with CML. Healthcare providers may recommend this medication to help control the disease and improve the quality of life for affected individuals. By taking Celonib 400 mg tablet, patients can expect to experience a stabilization of their condition over time. This can lead to more manageable health outcomes and a better prognosis.
• The administration of Celonib 400 mg tablet is typically guided by a healthcare professional who monitors the patient's response to treatment. This careful oversight ensures that the medication is effective and adjusted as necessary. Many patients find that Celonib 400 mg tablet provides a critical component of their overall cancer management strategy. Its role in treating CML underscores the importance of personalized medicine in oncology.
Benefits
Celonib 400 mg Tablet helps to reduce the size of cancerous tumors and slow the growth of cancer cells.
Celonib 400 mg can be used as part of a treatment plan to help increase the chances of remission or cure in patients with certain types of cancer.
Celonib 400 mg Strip can help to reduce the number and severity of cancer-related symptoms, such as fatigue, pain, and nausea.
Celonib Tablet can be taken orally, which makes it easier for patients to take the medication, and Celonib Tablet has relatively few side effects compared to other cancer treatments, such as chemotherapy.
Side Effects
Adverse reactions may occur with the use of Celonib 400 mg Tablet. Should you notice any of these side effects, it is advisable to consult your doctor or healthcare professional without delay. Your doctor can offer guidance on managing or alleviating these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Joint Pain
• Bone pain
• Muscle Cramps
• Sweating
• Watery Eyes
• Pink Eyes
• Flushing
• Itching
• Hair loss
Common Side Effects
• Shortness Of Breath
• Irregular Heartbeats
• Chest Pain
• Blistered skin
• Blood in Stool
• Severe Abdominal Pain and Bloating
• Blood in sputum
• High Fever
• Intestinal Bleeding
• Hepatic problems
• Diarrhea
• Dry mouth
• Loss of appetite
• Weight loss
• Headache
• Nail Color Changes
• Chills
• Sore throat
• Frequent Urination
• Tiredness
How To Use
Imatinib Tablet 400 mg can be taken with food or as directed by your doctor. It is best to take the same time daily to improve the clinical condition. If you miss a dose of Anti-cancer Drug Celonib take your next dose at your regularly scheduled time. The dose and duration of remedy will depend upon your condition. Do not stop taking this medicine without consulting your doctor.
Safety Advice
• Alcohol: The consumption of alcohol is generally not recommended when using Celonib 400 mg due to the increased risk of liver damage. It is best to either avoid alcohol altogether or limit its consumption while undergoing any medication.
• Kidney: Anti-cancer Drug Celonib should be used with mild kidney disease patients (CrCl 40 to <60 mL/min): Doses >600 mg/day are not recommended and moderate kidney patients (CrCl 20 to <40 mL/min). Decrease dose by 50%; may increase future doses if tolerated. Celonib 400 mg Tablet used in caution patients with severe kidney disease take 100-mg/day dose was tolerated.
• Breastfeeding: The excretion of Celonib 400 mg in human milk is currently unknown. Considering that various drugs, including other anthracyclines, are excreted in human milk and the possibility of severe adverse reactions in nursing infants from Celonib 400 mg Tablet, it is recommended that lactating women refrain from breastfeeding while undergoing treatment with Celonib 400 mg and for a minimum of 7 days after the final dose.
• Liver: Patients with liver disease should exercise caution when using Celonib Tablet. It is crucial for individuals with liver disease to closely observe their liver function while using Celonib 400 mg Tablet and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Celonib 400 mg Tablet may be necessary for patients with liver disease.
• Pregnancy: The use of Celonib 400 mg Tablet during pregnancy may not be safe, as indicated by animal studies that suggest potential harm to the developing foetus. However, if you are currently pregnant or planning to become pregnant, it is crucial to consult your doctor about the potential risks and benefits of using Celonib Tablet during pregnancy. Your doctor will be able to assist you in making the most appropriate decision for the health and well-being of both you and your baby.
• Driving: Your doctor's instructions should be strictly followed, especially if you encounter any side effects from Celonib Tablet. These side effects, such as dizziness, fatigue, and difficulty concentrating and coordinating, have the potential to hinder your capability to drive a vehicle safely. Taking necessary precautions, such as refraining from driving or operating heavy machinery, is essential to ensure your well-being while using Celonib 400 mg.